Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Fanny Legrand"'
Autor:
Andrea C. Bohrer, Ehydel Castro, Claire E. Tocheny, Maike Assmann, Benjamin Schwarz, Eric Bohrnsen, Michelle A. Makiya, Fanny Legrand, Kerry L. Hilligan, Paul J. Baker, Flor Torres-Juarez, Zhidong Hu, Hui Ma, Lin Wang, Liangfei Niu, Zilu Wen, Sang H. Lee, Olena Kamenyeva, Keith D. Kauffman, Michele Donato, Alan Sher, Daniel L. Barber, Laura E. Via, Thomas J. Scriba, Purvesh Khatri, Yanzheng Song, Ka-Wing Wong, Catharine M. Bosio, Amy D. Klion, Katrin D. Mayer-Barber
Publikováno v:
Cell Reports, Vol 40, Iss 4, Pp 111144- (2022)
Summary: Influx of eosinophils into the lungs is typically associated with type II responses during allergy and fungal and parasitic infections. However, we previously reported that eosinophils accumulate in lung lesions during type I inflammatory re
Externí odkaz:
https://doaj.org/article/4cc9d670630f4c0ab39dbfc2f415fe75
Autor:
Fanny Legrand, Virginie Driss, Gaëtane Woerly, Sylvie Loiseau, Emmanuel Hermann, Jean-Jacques Fournié, Laurent Héliot, Virginie Mattot, Fabrice Soncin, Marie-Lise Gougeon, David Dombrowicz, Monique Capron
Publikováno v:
PLoS ONE, Vol 4, Iss 6, p e5926 (2009)
BACKGROUND:Eosinophils are effector cells during parasitic infections and allergic responses. However, their contribution to innate immunity has been only recently unravelled. METHODOLOGY/PRINCIPAL FINDINGS:Here we show that human eosinophils express
Externí odkaz:
https://doaj.org/article/6b1160bccff7478ab6913f31ef1b2bcd
Autor:
Kerry Hilligan, Fanny Legrand
SUMMARYInflux of eosinophils into the lungs is typically associated with type-II responses during allergy, fungal and parasitic infections. However, we previously reported that eosinophils accumulate in lung lesions during type-I inflammatory respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09b16afda7a0c4e03e413431eddff4f4
https://doi.org/10.1101/2022.02.18.480919
https://doi.org/10.1101/2022.02.18.480919
Autor:
Michelle Makiya, Amy D. Klion, Roshan Ramanathan, Nicole Holland-Thomas, Jennifer Stoddard, JeanAnne Ware, Jesica A. Herrick, Fanny Legrand, Thomas B. Nutman, Reagan H. Thompson, Shakuntala Rampertaap, Michael P. Fay
Publikováno v:
Clinical Infectious Diseases. 73:e1624-e1631
Background Diethylcarbamazine citrate (DEC) treatment of loiasis is complicated by adverse reactions that are correlated with the number of circulating microfilariae (mf). The cause of these reactions is unknown, but they are accompanied by a dramati
Autor:
Fanny Legrand
Publikováno v:
Allergy. 76:937-939
Autor:
Robert O Emeh, Amy D. Klion, Elizabeth Chen, Fanny Legrand, Francesca Levi-Schaffer, Nadine Landolina, Ilan Zaffran
Publikováno v:
Allergy
Background Siglec-7 is an inhibitory receptor (IR) expressed on human blood eosinophils. Whereas activation of other IRs, including Siglec-8 and CD300a, has been shown to downregulate eosinophil function, little is known about the role of Siglec-7 on
Autor:
Fanny, Legrand
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2241
Eosinophils are granulocytes involved mainly in allergic inflammation and parasitic responses and constitute 1-5% of the circulating leukocytes in human healthy subjects. New immunotherapies targeting eosinophils have been developed and evaluated rec
Autor:
Fanny Legrand
Publikováno v:
Methods in Molecular Biology ISBN: 9781071610947
Eosinophils are granulocytes involved mainly in allergic inflammation and parasitic responses and constitute 1-5% of the circulating leukocytes in human healthy subjects. New immunotherapies targeting eosinophils have been developed and evaluated rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96f7b68dd20b858bccccafe883279671
https://doi.org/10.1007/978-1-0716-1095-4_3
https://doi.org/10.1007/978-1-0716-1095-4_3
Autor:
Amy D. Klion, Manasi Gadkari, Michelle Makiya, Kindra Stokes, Paneez Khoury, Luis M. Franco, Fanny Legrand, Zonghui Hu
Publikováno v:
Allergy. 73:2076-2079
Autor:
Bienvenu Etogo Ondigui, Jesica A. Herrick, Amy D. Klion, Thomas B. Nutman, Michael P. Fay, Steve Mbickmen Tchana, Konrad Nguluwe, Jean Bopda, Fanny Legrand, Raceline Kamkumo Gounoue, Godwin Nchinda, Michelle Makiya, Simon Metenou, Joseph Kamgno, Celine Montavon
Publikováno v:
Clinical Infectious Diseases. 64:1017-1025
Background Severe adverse reactions have been observed in individuals with Loa loa infection treated with either diethylcarbamazine (DEC), the drug of choice for loiasis, or ivermectin (IVM), which is used in mass drug administration programs for con